GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

Greater hospital COVID-19 burden is associated with an increased risk for in-hospital adverse events (AEs) among patients with and without COVID-19 in the United States.

Sugar restriction during the first 1,000 days after conception lowers a child's risk for later developing type 2 diabetes and hypertension.

Family history of colorectal cancer is associated with a higher risk for adenoma, nonadvanced adenoma, advanced adenoma, and advanced neoplasia.

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.

Robot-assisted surgery and laparoscopic minimally invasive approaches for treating esophageal carcinoma have the most favorable postoperative outcomes.

A parent-administered intervention reducing screen time before bed was associated with improved sleep efficiency among toddlers.

Expanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could avert 42,000 deaths annually ...

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial ...

There is a small inverse association between plasma omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) and cancer.

Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D).

What is the history of diabetes, when was the first National Diabetes Month, and how have diabetes statistics changed over ...